Pawlowski J E, Penning T M
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104-6084.
J Biol Chem. 1994 May 6;269(18):13502-10.
The overexpression and purification of recombinant rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase (3 alpha-HSD; EC 1.1.1.50) in Escherichia coli are described. The properties of the homogeneous recombinant 3 alpha-HSD (r3 alpha-HSD) confirm that a single polypeptide can function as a HSD, as a dihydrodiol dehydrogenase, and as an aromatic aldehyde, ketone, and quinone reductase. Cys-170, Cys-242, and Cys-217, implicated by bromoacetoxysteroid affinity-labeling agents as points of contact for the C-3, C-11, and C-17 positions of steroid ligands, were mutated to alanines. Unexpectedly, the homogeneous C170A and C242A mutants were kinetically similar to wild-type r3 alpha-HSD. By contrast, the C217A mutant gave Km values that were 4-fold higher for androstanedione and 2-fold higher for NADH. Inspection of the recently solved crystal structure of rat liver 3 alpha-HSD (Hoog, S. S., Pawlowski, J. E., Alzari, P. M., Penning, T. M., and Lewis, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2517-2521) places Cys-170 and Cys-242 on the periphery of an alpha/beta-barrel so that they cannot be involved in catalysis of steroid recognition. This demonstrates that bromoacetoxysteroid affinity-labeling agents may provide misleading information regarding the topography of steroid hormone binding sites. When NADPH was modeled into the crystal structure of 3 alpha-HSD, Tyr-55 was implicated as the general acid, since it is in close proximity to the C-4 position of the nicotinamide ring and could polarize the substrate carbonyl. In support of this model, the purified Y55F mutant was found to be catalytically inactive, but still formed an E-NADPH complex (measured by fluorescence titration) and an E-NADH-testosterone complex (measured by equilibrium dialysis). The ability of the Y55F mutant to form binary and ternary complexes, but not aid in hydride transfer, is consistent with Tyr-55 acting as the general acid. 3 alpha-HSD is a member of the aldo-keto reductase superfamily, and Tyr-55 is invariant in members of this family where it may perform a similar function. Tyr-205 is present in a pentapeptide sequence that is conserved in HSDs that belong to the short-chain alcohol dehydrogenase family and has been implicated as the general acid within these enzymes. The Y205F mutant was found to be kinetically similar to wild-type r3 alpha-HSD.(ABSTRACT TRUNCATED AT 400 WORDS)
本文描述了重组大鼠肝脏3α-羟基类固醇/二氢二醇脱氢酶(3α-HSD;EC 1.1.1.50)在大肠杆菌中的过表达及纯化。纯化后的重组3α-HSD(r3α-HSD)特性表明,单一多肽可作为HSD、二氢二醇脱氢酶以及芳香醛、酮和醌还原酶发挥作用。通过溴乙酰氧基类固醇亲和标记剂确定与类固醇配体的C-3、C-11和C-17位接触点的半胱氨酸残基Cys-170、Cys-242和Cys-217被突变为丙氨酸。出乎意料的是,均一的C170A和C242A突变体在动力学上与野生型r3α-HSD相似。相比之下,C217A突变体的雄甾烷二酮Km值高4倍,NADH的Km值高2倍。对最近解析的大鼠肝脏3α-HSD晶体结构(Hoog, S. S., Pawlowski, J. E., Alzari, P. M., Penning, T. M., and Lewis, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2517 - 2521)的研究表明,Cys-170和Cys-242位于α/β-桶的外围,因此它们不参与类固醇识别的催化过程。这表明溴乙酰氧基类固醇亲和标记剂可能会提供有关类固醇激素结合位点拓扑结构的误导性信息。当将NADPH模拟到3α-HSD的晶体结构中时,酪氨酸残基Tyr-55被认为是通用酸,因为它靠近烟酰胺环的C-4位,可使底物羰基极化。支持该模型的是,纯化后的Y55F突变体没有催化活性,但仍能形成E-NADPH复合物(通过荧光滴定法测定)和E-NADH-睾酮复合物(通过平衡透析法测定)。Y55F突变体形成二元和三元复合物但不参与氢化物转移的能力,与Tyr-55作为通用酸的作用一致。3α-HSD是醛酮还原酶超家族的成员,Tyr-55在该家族成员中是不变的,可能发挥类似的功能。酪氨酸残基Tyr-205存在于短链醇脱氢酶家族的HSD中保守的五肽序列中,被认为是这些酶中的通用酸。发现Y205F突变体在动力学上与野生型r3α-HSD相似。(摘要截断于400字)